SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $6,055,804 | +301634.1% | 62,800 | +331.3% | 0.05% | +58.1% |
Q1 2023 | $2,007 | -49.1% | 14,561 | -52.1% | 0.03% | -60.3% |
Q4 2022 | $3,941 | -99.9% | 30,412 | -13.7% | 0.08% | -7.1% |
Q3 2022 | $3,896,000 | +1039.2% | 35,248 | +704.2% | 0.08% | +950.0% |
Q1 2022 | $342,000 | +40.7% | 4,383 | +62.3% | 0.01% | +100.0% |
Q4 2021 | $243,000 | -94.5% | 2,701 | -95.2% | 0.00% | -95.2% |
Q2 2021 | $4,405,000 | +812.0% | 56,657 | +773.8% | 0.08% | +730.0% |
Q1 2021 | $483,000 | +0.8% | 6,484 | +130.6% | 0.01% | -28.6% |
Q4 2020 | $479,000 | -78.7% | 2,812 | -80.0% | 0.01% | -87.5% |
Q2 2020 | $2,250,000 | -58.2% | 14,034 | -65.6% | 0.11% | -40.4% |
Q2 2018 | $5,388,000 | +480.6% | 40,761 | +48.1% | 0.19% | +571.4% |
Q2 2017 | $928,000 | -61.3% | 27,517 | -66.0% | 0.03% | -62.2% |
Q1 2017 | $2,395,000 | -81.9% | 80,929 | -62.5% | 0.07% | -76.2% |
Q3 2016 | $13,260,000 | +1617.6% | 215,933 | +798.1% | 0.31% | +1096.2% |
Q3 2015 | $772,000 | – | 24,042 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |